Intraocular Pressure Changes after Intravitreal Bevacizumab or Ranibizumab Injection: A Retrospective Study

PURPOSE: To determine intraocular pressure (IOP) changes after intravitreal bevacizumab or ranibizumab injection administered for various retinal disorders. METHODS: A retrospective chart review of 796 eyes of 574 patients receiving intravitreal ranibizumab (0.5 mg) and/or bevacizumab (1.25 mg) inje...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansoori, Tarannum, Agraharam, Satish Gooty, Manwani, Sunny, Balakrishna, Nagalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102956/
https://www.ncbi.nlm.nih.gov/pubmed/34084950
http://dx.doi.org/10.4103/JOCO.JOCO_5_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102956/
https://www.ncbi.nlm.nih.gov/pubmed/34084950
http://dx.doi.org/10.4103/JOCO.JOCO_5_20

Ejemplares similares